ABT vs UTI · P/E 25, rev $44.33B vs P/E 31, rev $835.6M
Abbott Laboratories (ABT) versus Universal Technical Institute Inc (UTI) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Universal Technical Institute Inc (UTI) is a education & training services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported UTI revenue for 2025-09-30 was $835.6M. Net income was $63.0M. UTI currently screens at market cap $1.76B and trailing P/E 30.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. UTI currently screens at market cap $1.76B and trailing P/E 30.8.
Not investment advice. Open the ABT and UTI stock pages for the full models.
Not investment advice.